Adaptogenics Health Corp. Eyes Opportunities Beyond Standard Peptides as Policy Opens Pharmacy and Telehealth Channels

By The Building Texas Show•
Adaptogenics Health Corp. is positioning itself to develop enhanced peptide delivery technologies and a GLP-1 companion initiative as a potential federal interim policy could open specialty pharmacy and telehealth channels for peptides.

Found this article helpful?

Share it with your network and spread the knowledge!

Adaptogenics Health Corp. Eyes Opportunities Beyond Standard Peptides as Policy Opens Pharmacy and Telehealth Channels

Adaptogenics Health Corp. (CSE: ADPT) is positioning itself for a potential shift in how peptides reach patients, as the federal government works on an interim peptide access policy that would allow specialty pharmacies to produce certain peptides while formal rulemaking proceeds. The company, Adaptogenics Health Corp., plans to develop delivery technologies to improve the stability, exposure, administration and performance of selected peptides, and has acquired nutritional research assets developed by Berkwood Research to support a GLP-1 companion initiative.

U.S. Health Secretary Robert F. Kennedy Jr. has made his view plain: Americans are going to buy peptides anyway, so the government should make sure they come from inspected sources. Kennedy laid out his case in a Fox News appearance this month, explaining that the administration is working on an interim access policy that would let specialty pharmacies produce certain peptides while formal rulemaking proceeds. That push could reshape how peptides reach patients, opening new opportunities for pharmacies, telehealth platforms and companies with something more to offer than standard ingredients.

For Texas, the implications are notable. The state has become a hub for telehealth and pharmacy innovation, and a policy that legitimizes specialty pharmacy production of peptides could create new economic channels for Texas-based businesses. Companies that can differentiate themselves through delivery technology or companion products—like Adaptogenics’ planned GLP-1 initiative—may find a more receptive market as regulatory clarity improves. Read More>>

The latest news and updates relating to ADPT are available in the company’s newsroom at https://nnw.fm/ADPT. The announcement was disseminated through NetworkNewsWire, a specialized communications platform focused on financial news and content distribution for private and public companies and the investment community. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers access to a vast network of wire solutions via InvestorWire, article and editorial syndication to 5,000+ outlets, enhanced press release enhancement, social media distribution and tailored corporate communications solutions. Full terms of use and disclaimers are available at https://www.NetworkNewsWire.com/Disclaimer.